Pharvaris N.V. (PHVS)
Last updated: 2026-11-19 06:34:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
Pharvaris N.V. (PHVS) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $31.63, with a market capitalization of $2.29B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $23.15 to $43.25. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$2.29B | |
$32.24 | |
$32.82 | |
$31.26 | |
$32.28 | |
341.12K | |
764.62K | |
-- | |
$43.25 | |
$23.15 | |
-- | |
2026-09-30 |
Pharvaris N.V. (PHVS) Latest Closing Stock Price
Pharvaris N.V. (PHVS) last closed at $31.63 as of 2026-11-19 00:31:00, down 2.39% ($0.77) from the previous close of $32.28.
During the latest regular trading session, PHVS traded between $31.26 and $32.82, with a volume of 341.12K shares. The closing price was near the lower end and near the middle of its 52-week range.
Pharvaris N.V. (PHVS) 7-Day Stock Price Change
Over the past seven days, Pharvaris N.V. (PHVS) moved from $33.99 to $31.63, representing a decline of 6.94% ($2.36).
The stock traded between $31.22 and $35.05 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 380.78 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
PHVS 52-Week Price Position
Position in Range: 42.2%
PHVS is currently trading at $31.63, placing it 42.2% of the way from its 52-week low of $23.15 to its 52-week high of $43.25. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Pharvaris N.V. (PHVS)?
Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks. The company is also running open-label extension studies in both on-demand (RAPIDe-2) and prophylactic (CHAPTER-4) settings to collect long-term safety and efficacy data in HAE patients.
Pharvaris N.V. Information
| Employees | 129 |
| Exchange | NASDAQ |
| Company Website |
PHVS News
Latest news related to Pharvaris N.V. and PHVS stock.
- Read Full Article
- Read Full Article
Pharvaris Q3 EPS $(0.77) Beats $(0.82) Estimate
Pharvaris (NASDAQ:PHVS) reported quarterly losses of $(0.77) per share which beat the analyst consensus estimate of $(0.82) by 6.1 percent. This is a 11.59 percent decrease over losses of $(0.69) per share from the same
- Read Full Article
Pharvaris Ends Q3 With €283M Cash
- Read Full Article
Pharvaris Sees US NDA Filing For Deucrictibant XR In Prophylaxis In 1H 2027
- Read Full Article
Pharvaris Sees Topline Data From Part 1 Of Phase 3 CREAATE Study In Q1 2027
Ways to Trade PHVS at MEXC
How to Buy Pharvaris N.V. (PHVS) Stock on MEXC
Eligible investors can buy real shares of Pharvaris N.V. (PHVS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Pharvaris N.V. (PHVS) stock price today?
2.Is PHVS stock going up or down today?
3.What is PHVS pre-market price?
4.What is PHVS after-hours price?
5.Is PHVS stock trading now?
6.Where does PHVS sit relative to its 52-week high and low?
7.What sector is Pharvaris N.V. in?
8.What is Pharvaris N.V.'s market capitalization and where is it listed?
9.How is PHVS valued in terms of P/E ratio and EPS?
10.Does Pharvaris N.V. pay a dividend?
Explore More US Stocks
Compliance Disclosure and Data Source
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to PHVS, including Stocks, Tokenized Stocks, and Stock Futures.
Disclaimer
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Search Stocks
PHVS Stock Calculator
Estimate the value between PHVS shares and USD.
PHVS Shares to USD
1.00 PHVS shares = 31.631 USD
Calculations are estimates based on the latest available price and are for reference only.


